ConductScience.org, home

Paper24248554

Good maths is needed to understand CMV data in glioblastoma.

Wick W and 2 others. Int J Cancer, 2014. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Good maths is needed to understand CMV data in glioblastoma. Papers, record 24248554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24248554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Good maths is needed to understand CMV data in glioblastoma.
PubMed
Journal
Int J Cancer
PubMed
Year
2014
PubMed
Publication types
Letter, Comment
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2021-01-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wick WWolfgang
2Wick AAntje
3Platten MMichael

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Brain NeoplasmsMajor topic
GanciclovirMajor topic
GlioblastomaMajor topic
Animals
Humans

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on24004141Survival in patients with glioblastoma receiving valganciclovir.https://conductscience.org/library/papers/24004141

Source PubMed

Download CSV of comments and corrections

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
36079151Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.J Clin Med2022https://conductscience.org/library/papers/36079151PubMed
33405205Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy.J Neurovirol2021https://conductscience.org/library/papers/33405205PubMed
28919997Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients.Oncoimmunology2017https://conductscience.org/library/papers/28919997PubMed
27402152A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.Acta Neuropathol Commun2016https://conductscience.org/library/papers/27402152PubMed
25722939The future of high-grade glioma: Where we are and where are we going.Surg Neurol Int2015https://conductscience.org/library/papers/25722939PubMed
25682092Cytomegalovirus and glioblastoma; controversies and opportunities.J Neurooncol2015https://conductscience.org/library/papers/25682092PubMed
24523454CMV infection and glioma, a highly controversial concept struggling in the clinical arena.Neuro Oncol2014https://conductscience.org/library/papers/24523454PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24248554

GET https://conductscience.org/api/papers/v1/24248554/authors